secwatch.observer — SEC 8-K summary
======================================

Issuer:     Elevance Health, Inc. (ELV)
CIK:        0001156039
Form:       8-K
Filed at:   2023-05-11T23:59:59+00:00
Accession:  0001156039-23-000067
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Elevance Health annual meeting: directors elected, say-on-pay approved, two shareholder proposals defeated
--------------------------------------------------------------------------------

- All four director nominees elected with >96% of votes cast; terms expire 2026.
- Advisory vote on executive compensation approved with 187.5M for (93.6% of votes cast).
- Shareholder proposal for special meeting rights (10% threshold) not approved: 91.7M for vs 107.7M against.
- Shareholder proposal on third-party reporting rejected: 16.1M for vs 181.8M against.
- Ratification of Ernst & Young as auditor for 2023 passed with 197.1M for (92.3% of votes cast).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1156039/000115603923000067/0001156039-23-000067-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1156039/000115603923000067/elv-20230510.htm
  HTML page:      https://secwatch.observer/filing/0001156039-23-000067

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer